Breaking Cataract Patient Education Recommendation Surgery Treatment Global Spotlight: The Most Cost-Effective Countries for Cataract Surgery Eylül 10, 2025
Breaking Clinical Trial Myopia Treatment OCT changes with low-level red light therapy for myopia in children Ağustos 26, 2025
Breaking Cataract Cornea Hyperopia LASIK Myopia Patient Education PRK Surgery Next-generation IOLs advance complex cataract care Ağustos 26, 2025
Breaking Cataract Patient Education Surgery Technology Alcon presenting at APACRS 2025 Ağustos 21, 2025
Home Patient Education Infographic: landmark trials in neuro-ophthalmology – results of the REVERSE trial for unilateral gene therapy rAAV2/2-ND4 in leber hereditary optic neuropathy – Nature Share your love
Infographic: landmark trials in neuro-ophthalmology – results of the REVERSE trial for unilateral gene therapy rAAV2/2-ND4 in leber hereditary optic neuropathy Nature Source: Author: | Date: 2025-07-16 07:00:00 Source: Author: | Date: 2025-07-16 07:00:00 Share your love Previous Yazı Infographic: Landmark trials in Neuro-Ophthalmology—results of the phase II Idiopathic Intracranial Hypertension Pressure Trial | Eye - Nature Next Yazı EYE-Llama, an in-domain large language model for ophthalmology - ScienceDirect.com Related Posts AAO 2026 Highlights Hospital Ophthalmology Coverage Gaps and Growing Reimbursement PressuresEkim 11, 2026 Inflammasome Therapeutics’ Kamuvudine K8 Reduces Geographic Atrophy Lesion Growth by 54% in Phase 2 StudyEkim 9, 2026 GenSight Biologics Publishes GS030 PIONEER Optogenetic Therapy Results in the New England Journal of MedicineEkim 8, 2026 Leave a ReplyCancel ReplyE-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Yorum gönder
AAO 2026 Highlights Hospital Ophthalmology Coverage Gaps and Growing Reimbursement PressuresEkim 11, 2026
Inflammasome Therapeutics’ Kamuvudine K8 Reduces Geographic Atrophy Lesion Growth by 54% in Phase 2 StudyEkim 9, 2026
GenSight Biologics Publishes GS030 PIONEER Optogenetic Therapy Results in the New England Journal of MedicineEkim 8, 2026
